CoChat

Bifidobacterium longum mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis

Open access

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

Gut microbial disturbance affects allergic diseases including asthma, atopic dermatitis (AD) via the aberrant immune response. Some Bifidobacterial species and strains have been reported to improve AD via modulating immune-microbe interactions in patients. However, the effective metabolites and mechanism of alleviating AD in bifidobacteria remain to be elucidated. This study aimed to explore the microbial metabolite and mechanism of Bifidobacterium longum to improve AD. Based on shotgun metagenomic sequencing and UHPLC Q-Exactive-MS targeted metabolic experiments in vitro and in vivo, we focused on tryptophan metabolism and indole derivatives, which are endogenous ligands for aryl hydrocarbon receptor (AHR). Indole-3-carbaldehyde (I3C), a tryptophan metabolite of B. longum CCFM1029 activated AHR-mediated immune signaling pathway to improve AD symptoms in animal and clinical experiments. B. longum CCFM1029 upregulated tryptophan metabolism and increased I3C to suppress aberrant T helper 2 type immune responses, but these benefits were eliminated by AHR antagonist CH223191. Furthermore, B. longum CCFM1029 reshaped gut microbial composition in AD patients, increased fecal and serum I3C, and maintained the abundance of Lachnospiraceae related to tryptophan metabolism of gut microbiota. The results suggested that based on the interactions of the gut-skin axis, B. longum CCFM1029 upregulated tryptophan metabolism and produced I3C to activate AHR-mediated immune response, alleviating AD symptoms. Indole derivates, microbial metabolites of tryptophan, may be the potential metabolites of bifidobacteria to alleviate AD via the AHR signaling pathway.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/19490976.2022.2044723

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Effects of B. longum CCFM1029 on gut microbial composition and tryptophan metabolism in mice. (a) Principal coordinates analysis for gut microbiota. (b) Gut microbial composition at the phylum level. (c) Changes in gut microbiota at the genus level. (d) Gene functional alterations of gut microbiota based on KEGG pathways. (e) Alterations of tryptophan metabolites in fecal samples. KEGG, Kyoto Encyclopedia of Genes and Genomes; DNFB, 2,4-dinitrofluorobenzene; CCFM1029, B. longum CCFM1029; KYN: Kynurenine; IA: indole-3-acrylic acid; IAA: indole acetic acid; ILA: indole-3-lactic acid; IPA: indole-3-propionic acid; I3C: indole-3-carbaldehyde.
Figure 1. Effects of B. longum CCFM1029 on gut microbial composition and tryptophan metabolism in mice. (a) Principal coordinates analysis for gut microbiota. (b) Gut microbial composition at the phylum level. (c) Changes in gut microbiota at the genus level. (d) Gene functional alterations of gut microbiota based on KEGG pathways. (e) Alterations of tryptophan metabolites in fecal samples. KEGG, Kyoto Encyclopedia of Genes and Genomes; DNFB, 2,4-dinitrofluorobenzene; CCFM1029, B. longum CCFM1029; KYN: Kynurenine; IA: indole-3-acrylic acid; IAA: indole acetic acid; ILA: indole-3-lactic acid; IPA: indole-3-propionic acid; I3C: indole-3-carbaldehyde.CC BY-NC · PubMed Central
Figure 2. I3C was derived from B. longum CCFM1029 catabolizing tryptophan. (a-b) The analysis for the contribution of gut microbes for tryptophan metabolism. (c) The correlation analysis between gut microbial alteration and changes in I3C. (d) Evaluation of B. longum CCFM1029 metabolizing tryptophan in vitro. (e) Comparison for I3C production of B. longum strains metabolizing tryptophan in vitro. ***p < .001, ****p < .0001 vs CCFM1029 group (one-way ANOVA test).
Figure 2. I3C was derived from B. longum CCFM1029 catabolizing tryptophan. (a-b) The analysis for the contribution of gut microbes for tryptophan metabolism. (c) The correlation analysis between gut microbial alteration and changes in I3C. (d) Evaluation of B. longum CCFM1029 metabolizing tryptophan in vitro. (e) Comparison for I3C production of B. longum strains metabolizing tryptophan in vitro. ***p < .001, ****p < .0001 vs CCFM1029 group (one-way ANOVA test).CC BY-NC · PubMed Central
Figure 3. B. longum CCFM1029 inhibited AD symptoms via AHR-mediated immune responses. (a) Effects of B. longum CCFM1029 on skin inflammation. (b) Alteration of ear thickness in mice. (c) Changes in serum IgE (***p < .001, ****p < .0001, Two-way ANOVA followed Tukey’s multiple comparisons test). (d) Fold-change for AHR expression. (e-g) TSLP, IL-4, and IL-5 in skin lesions. (h) Effects of B. longum CCFM1029 on serum I3C. *p < .05, **p < .01, ***p < .001, ****p < .0001 vs DNFB group (one-way ANOVA test). AHR, aryl hydrocarbon receptors; TSLP, thymic stromal lymphopoietin.
Figure 3. B. longum CCFM1029 inhibited AD symptoms via AHR-mediated immune responses. (a) Effects of B. longum CCFM1029 on skin inflammation. (b) Alteration of ear thickness in mice. (c) Changes in serum IgE (***p < .001, ****p < .0001, Two-way ANOVA followed Tukey’s multiple comparisons test). (d) Fold-change for AHR expression. (e-g) TSLP, IL-4, and IL-5 in skin lesions. (h) Effects of B. longum CCFM1029 on serum I3C. *p < .05, **p < .01, ***p < .001, ****p < .0001 vs DNFB group (one-way ANOVA test). AHR, aryl hydrocarbon receptors; TSLP, thymic stromal lymphopoietin.CC BY-NC · PubMed Central
Figure 4. Effects of B. longum CCFM1029 on patients with AD. (a) Flowchart of the status of patients in the placebo and CCFM1029 groups. (b) Effect of B. longum CCFM1029 on SCORAD and DLQI indicators. (c) Effects of B. longum on serum markers. (d) Effects of B. longum CCFM1029 on indole derivatives in fecal and serum samples. *p < .05 (Kruskal–Wallis test followed Dunn’s multiple comparisons test). SCORAD, scoring atopic dermatitis index; DLQI, dermatology life quality index; NR-B, non-response subgroup (before CCFM1029 treatment); NR, non-response subgroup (after CCFM1029 treatment); R-B, response subgroup (before CCFM1029 treatment); R, response subgroup (after CCFM1029 treatment).
Figure 4. Effects of B. longum CCFM1029 on patients with AD. (a) Flowchart of the status of patients in the placebo and CCFM1029 groups. (b) Effect of B. longum CCFM1029 on SCORAD and DLQI indicators. (c) Effects of B. longum on serum markers. (d) Effects of B. longum CCFM1029 on indole derivatives in fecal and serum samples. *p < .05 (Kruskal–Wallis test followed Dunn’s multiple comparisons test). SCORAD, scoring atopic dermatitis index; DLQI, dermatology life quality index; NR-B, non-response subgroup (before CCFM1029 treatment); NR, non-response subgroup (after CCFM1029 treatment); R-B, response subgroup (before CCFM1029 treatment); R, response subgroup (after CCFM1029 treatment).CC BY-NC · PubMed Central
Figure 5. Effects of B. longum CCFM1029 on gut microbiota in patients. (a) NMDS analysis for β diversity of gut microbiota. (b-c) Gut microbial changes at the phylum level in patients. (d) LEfSe analysis for differential taxa between before and after placebo intervention (p < .05, LDA score (log10)>2.0). (e) Cladogram for differentially abundant taxa in the CCFM1029-B group, NR subgroup, and R subgroup. (f) Changes in the proportions of Sutterella and Lachnospiraceae. (g) The abundance of functional genes related to tryptophan metabolism. *p < .05 vs CCFM1029-B, ****p < .0001 (one-way ANOVA test). NMDS, non-metric multidimensional scaling. LEfSe, linear discriminant analysis Effect Size.
Figure 5. Effects of B. longum CCFM1029 on gut microbiota in patients. (a) NMDS analysis for β diversity of gut microbiota. (b-c) Gut microbial changes at the phylum level in patients. (d) LEfSe analysis for differential taxa between before and after placebo intervention (p < .05, LDA score (log10)>2.0). (e) Cladogram for differentially abundant taxa in the CCFM1029-B group, NR subgroup, and R subgroup. (f) Changes in the proportions of Sutterella and Lachnospiraceae. (g) The abundance of functional genes related to tryptophan metabolism. *p < .05 vs CCFM1029-B, ****p < .0001 (one-way ANOVA test). NMDS, non-metric multidimensional scaling. LEfSe, linear discriminant analysis Effect Size.CC BY-NC · PubMed Central
Figure 6. Experimental flow chart. HE: hematoxylin-eosin; KYN: Kynurenine.
Figure 6. Experimental flow chart. HE: hematoxylin-eosin; KYN: Kynurenine.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Cited by

See all 306

Metadata

Authors
Fang, Z., Pan, T., Li, L., Wang, H., Zhu, J., Zhang, H., Zhao, J., Chen, W., & Lu, W.
Affiliations
Jiangnan University (CN)
Corresponding author
Lu, Wenwei
Venue
Gut Microbes
Published
2022-03-03
Volume
14
Issue
1
Pages
2044723-2044723
ISSN
  • 1949-0976 (ISSN-L)
  • 1949-0984
OpenAlex
W4214851298
Cited by
273
References
44
Citations by year
2026: 68 · 2025: 82 · 2024: 74 · 2023: 41 · 2022: 7
FWCI
17.47
Type
journal article
Language
en
Open access
Licence
doi.org/10.1080/policies-text-data-mining (tdm)
Locations
  • Gut Microbes (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • the National Natural Science Foundation of China (31820103010, 32021005)
  • 111project
  • Project 111 (BP0719028)
  • the Postdoctoral Research Funding Scheme of Jiangsu Province (2021K018A)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
Bifidobacterium longum, atopic dermatitis, tryptophan metabolism, indole-3-carboxaldehyde, aryl hydrocarbon receptor, gut-skin axis, Th2 immune response, Lachnospiraceae, gut microbiota, microbial metabolites, CH223191
MeSH terms
Gastrointestinal Microbiome, Bifidobacterium longum, Animals, Bifidobacterium, Dermatitis, Atopic, Humans, Indoles, Tryptophan, Receptors, Aryl Hydrocarbon

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bifidobacterium longum mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis. https://app.cochat.ai/papers/10.1080/19490976.2022.2044723
The paper
Fang, Z., Pan, T., Li, L., Wang, H., Zhu, J., Zhang, H., Zhao, J., Chen, W., & Lu, W. (2022). Bifidobacterium longum mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis. Gut Microbes. https://doi.org/10.1080/19490976.2022.2044723

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.